Sunnybrook Health Sciences Centre: Depressive Disorder, Major trials
The registry lists 17 Depressive Disorder, Major studies with Sunnybrook Health Sciences Centre as lead sponsor. 6 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 1 2Phase 2 2Phase 3 1Phase 4 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Ketogenic Diet and Neuromodulation in Treatment Resistant DepressionNot yet recruitingNCT07376018Not applicable
- rTMS for Youth Inpatients With DepressionRecruitingNCT07140575Not applicable
- Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive DisorderRecruitingNCT07113665Phase 1
- Virtual Reality Reward Training and Transcranial Magnetic Stimulation for DepressionRecruitingNCT06178731Not applicable
- A Randomized Neuroimaging Trial of Psilocybin in DepressionRecruitingNCT06072898Phase 2
- Interleaved TMS-fMRI in Ultra-treatment Resistant DepressionRecruitingNCT05813093Not applicable
- Chart Review of Patients Undergoing Ketamine Treatments for DepressionCompletedNCT07099235
- Pilot Study of the Safety and Tolerability of L-DLPFC iTBS rTMS for MDD in MSStatus unknownNCT04621708Not applicable
- Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in DepressionCompletedNCT03977038
- Trial of MR-guided Focused Ultrasound for Treatment of Refractory Major DepressionCompletedNCT03421574Not applicable
- Investigation of Seasonal Variations of Brain Structure and Connectivity in SADCompletedNCT03313674Not applicable
- Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.CompletedNCT02593643Early Phase 1
- Mental Health Telemetry for Self-Management in Major DepressionCompletedNCT01999010Not applicable
- Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive DisorderTerminatedNCT01650740Not applicable
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
- Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive DisorderCompletedNCT00892463Phase 4
- Discontinuation Study Of Citalopram (Antidepressant) in Depressed AdolescentsWithdrawnNCT00249886Phase 3